MedTrace Logo

FFP Usage in Pediatric CV Surgery

NCT05819788 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 431

Last updated 2024-09-19

No results posted yet for this study

Summary

When small children undergo heart surgery with the heart-lung machine, in the past, blood products to help the blood clot such as Fresh Frozen Plasma (FFP) was routinely used in children under 10kg. With blood clot monitoring technology, we feel that it might not be necessary to expose all children to FFP. We want to determine if those children who did not receive FFP bleed more or require more blood products as compared to those who did receive FFP while on the heart lung machine.

Conditions

  • Coagulopathy
  • Congenital Heart Disease

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Principal Investigators

  • Mancho Ng, MD · University of Alberta

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-28
Primary Completion
2024-07-08
Completion
2024-07-08

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05819788 on ClinicalTrials.gov